Morgan Stanley (MS) Stake Boosted by Balasa Dinverno & Foltz LLC

Balasa Dinverno & Foltz LLC lifted its holdings in Morgan Stanley (NYSE:MS) by 17.9% during the fourth quarter, HoldingsChannel.com reports. The firm owned 12,309 shares of the financial services provider’s stock after purchasing an additional 1,865 shares during the period. Balasa Dinverno & Foltz LLC’s holdings in Morgan Stanley were worth $488,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of MS. Kiwi Wealth Investments Limited Partnership bought a new position in shares of Morgan Stanley in the third quarter worth about $4,912,000. ValueAct Holdings L.P. increased its stake in shares of Morgan Stanley by 11.2% in the third quarter. ValueAct Holdings L.P. now owns 20,810,470 shares of the financial services provider’s stock worth $969,144,000 after purchasing an additional 2,100,850 shares during the period. FMR LLC increased its stake in shares of Morgan Stanley by 4.4% in the second quarter. FMR LLC now owns 45,817,038 shares of the financial services provider’s stock worth $2,171,728,000 after purchasing an additional 1,936,093 shares during the period. Renaissance Technologies LLC increased its stake in shares of Morgan Stanley by 28.2% in the third quarter. Renaissance Technologies LLC now owns 4,654,200 shares of the financial services provider’s stock worth $216,746,000 after purchasing an additional 1,023,473 shares during the period. Finally, Robeco Institutional Asset Management B.V. increased its stake in shares of Morgan Stanley by 107.1% in the third quarter. Robeco Institutional Asset Management B.V. now owns 1,246,803 shares of the financial services provider’s stock worth $58,064,000 after purchasing an additional 644,811 shares during the period. Institutional investors and hedge funds own 84.99% of the company’s stock.

A number of equities analysts have recently commented on MS shares. UBS Group upgraded Morgan Stanley from a “market perform” rating to an “outperform” rating in a research note on Tuesday, October 16th. Oppenheimer upgraded Morgan Stanley to an “outperform” rating and set a $62.00 price objective on the stock in a research note on Tuesday, October 16th. Vining Sparks restated a “buy” rating and set a $60.00 price target on shares of Morgan Stanley in a research note on Tuesday, October 16th. Wells Fargo & Co upgraded Morgan Stanley from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $56.00 to $60.00 in a research note on Wednesday, October 24th. Finally, Zacks Investment Research upgraded Morgan Stanley from a “hold” rating to a “buy” rating and set a $50.00 price target on the stock in a research note on Tuesday, November 20th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $56.38.

Shares of MS opened at $42.45 on Wednesday. The company has a market capitalization of $72.95 billion, a PE ratio of 9.21, a price-to-earnings-growth ratio of 0.73 and a beta of 1.20. The company has a debt-to-equity ratio of 2.67, a quick ratio of 0.80 and a current ratio of 0.80. Morgan Stanley has a one year low of $36.74 and a one year high of $59.38.

Morgan Stanley (NYSE:MS) last announced its earnings results on Thursday, January 17th. The financial services provider reported $0.73 EPS for the quarter, missing the consensus estimate of $0.90 by ($0.17). The business had revenue of $8.55 billion during the quarter, compared to analyst estimates of $9.32 billion. Morgan Stanley had a return on equity of 12.08% and a net margin of 17.43%. The firm’s revenue was down 10.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.84 earnings per share. On average, sell-side analysts expect that Morgan Stanley will post 4.99 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 15th. Stockholders of record on Thursday, January 31st will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 2.83%. The ex-dividend date is Wednesday, January 30th. Morgan Stanley’s payout ratio is currently 26.03%.

In other news, insider Jeffrey S. Brodsky sold 15,565 shares of the business’s stock in a transaction that occurred on Friday, January 18th. The stock was sold at an average price of $43.38, for a total value of $675,209.70. Following the transaction, the insider now directly owns 112,420 shares of the company’s stock, valued at approximately $4,876,779.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.19% of the stock is owned by insiders.

TRADEMARK VIOLATION NOTICE: “Morgan Stanley (MS) Stake Boosted by Balasa Dinverno & Foltz LLC” was originally reported by Enterprise Leader and is owned by of Enterprise Leader. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://theenterpriseleader.com/2019/02/06/morgan-stanley-ms-stake-boosted-by-balasa-dinverno-foltz-llc.html.

Morgan Stanley Company Profile

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates Institutional Securities, Wealth Management, and Investment Management segments.

Featured Article: How to Track your Portfolio in Google Finance

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply